The trial is conducted at the Mays Cancer Center, part of the University of Texas at San Antonio’s Health Science Center.

Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company focused on delivering a new class of innovative immunotherapies for patients with cancer and other incurable diseases, announced today that a late ...

“Strength training is also really good for bone density because whenever you contract a muscle with force, that muscle, via a tendon, will pull on the bone, and that pulling on the bone is good for ...

Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular ...

The first patient has been dosed in a first-in-human phase 1/2 trial evaluating DS3790 in patients with relapsed or refractory B-cell non-Hodgkin lymphoma. DS3790 is a specifically engineered, ...

Vinhomes Green Paradise Can Gio is more than a coastal megacity. Within its ESG++ framework, social infrastructure evolves ...

Being proactive and following these tips could help keep your bones strong well into your golden years. Don't underestimate the power of sleep, healthy food and plenty of exercise.

The Netherlands' MedTech startups lead healthcare innovation through AI diagnostics, medical devices, and digital health ...

Eli Lilly delivered a robust 4Q25 beat, with revenue up 43% YoY and strong EPS growth, driven by its GLP-1 franchise. Check out my latest analysis on LLY stock.

The Royal Society of Chemistry is proud to announce that seven of the world's most influential scientists have been awarded ...

Amgen Inc. delivered strong operational performance across the board in 2025, and you can see that in the breadth of our business. Three of these, Repatha, Evenity, and TestSpire, all grew by more ...

Amgen Inc. ( AMGN) Q4 2025 Earnings Call February 3, 2026 4:30 PM EST ...